We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Advanced Hospital Robot Courier Debuts at the AACC Clinical Lab Expo

By LabMedica International staff writers
Posted on 31 Jul 2013
Print article
Image: The RoboCourier Autonomous Mobile Robot (Photo courtesy of Swisslog).
Image: The RoboCourier Autonomous Mobile Robot (Photo courtesy of Swisslog).
The latest innovation in hospital laboratory material-transport robotics is on display at the AACC (American Association for Clinical Chemistry) Clinical Lab Expo in Houston (TX, USA), from July 30-August 1, 2013.

Swisslog (Buchs, Switzerland), a global provider of integrated logistics solutions for warehouses, distribution centers, and hospitals, is staging the premier of its next-generation RoboCourier Autonomous Mobile Robot at the Clinical Lab Expo. Attendees can see the new RoboCourier in action at Swisslog's booth no. 4408.

The new RoboCourier features a complete redesign for better ergonomics and serviceability, updated software, improved storage capacity, and automatic interfaces for doors and elevators. The robot provides a system for secure transport of up to 45 kilograms of laboratory specimens, medications, supplies, and protected health information. It offers the smallest footprint available for automated transport and recharges from a standard wall outlet. A 360 degree turn radius allows RoboCourier to navigate tight spaces and narrow and crowded hallways, making it ideal for both intra- and inter-department deliveries.

Use of the RoboCourier will enable hospitals to automate scheduled and on-demand deliveries of laboratory samples, medications and other materials. Its autonomous operation frees users for more-critical activities.

"Automating manual transport of samples and medications frees technicians to focus on tasks that service patients," said Sandy Agnos, RoboCourier product manager at Swisslog. "Hospitals with RoboCourier have a simple, lean solution for improving their workflow processes without facility modification and can see a return on their investment in less than a year."

Related Links:
Swisslog


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
HbA1c Test
HbA1c Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.